Key Facts

EXPERT aims at developing a new off-the-shelf delivery system for RNA-based nanomedicines to treat cancer and cardiovascular disease. In the long term, the platform technology could be used for improving diagnostic and therapeutic options for patients with several other diseases.

Duration
Duration
60 months
Funding
Funding
14.9 Mio €
Partners
Partners
11

Countries involved

The Netherlands
Sweden
Belgium
Norway
Ireland
Hungary
Israel
France
Spain
Germany